Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study

车辆段 中枢性早熟 性早熟 医学 相(物质) 儿科 内科学 化学 激素 地理 考古 有机化学
作者
Karen Oerter Klein,Nelly Mauras,Sunil Nayak,Bhuvana Sunil,Blanca M Martinez-Placencia,Sanja Dragnic,Mayra Ballina,Qing Zhou,Alvina R. Kansra
出处
期刊:Journal of the Endocrine Society [Endocrine Society]
卷期号:7 (7) 被引量:1
标识
DOI:10.1210/jendso/bvad071
摘要

Abstract Context Treatment options for central precocious puberty (CPP) are important for individualization of therapy. Objective We evaluated the efficacy and safety of 6-month 45-mg leuprolide acetate (LA) depot with intramuscular administration. Methods LA depot was administered at weeks 0 and 24 to treatment-naïve (n = 27) or previously treated (n = 18) children with CPP in a phase 3, multicenter, single-arm, open-label study (NCT03695237). Week 24 peak-stimulated luteinizing hormone (LH) suppression (<4 mIU/mL) was the primary outcome. Secondary/other outcomes included basal sex hormone suppression (girls, estradiol <20 pg/mL; boys, testosterone <30 ng/dL), suppression of physical signs, height velocity, bone age, patient/parent-reported outcomes, and adverse events. Results All patients (age, 7.8 ± 1.27 years) received both scheduled study doses. At 24 weeks, 39/45 patients (86.7%) had LH suppressed. Six were counted as unsuppressed; 2 because of missing data, 3 with LH of 4.35−5.30 mIU/mL and 1 with LH of 21.07 mIU/mL. Through 48 weeks, LH, estradiol, and testosterone suppression was achieved in ≥86.7%, ≥97.4%, and 100%, respectively (as early as week 4 for LH and estradiol and week 12 for testosterone). Physical signs were suppressed at week 48 (girls, 90.2%; boys, 75.0%). Mean height velocity ranged 5.0 to 5.3 cm/year post-baseline in previously treated patients and declined from 10.1 to 6.5 cm/year at week 20 in treatment-naïve patients. Mean bone age advanced slower than chronological age. Patient/parent-reported outcomes remained stable. No new safety signals were identified. No adverse event led to treatment discontinuation. Conclusion Six-month intramuscular LA depot demonstrated 48-week efficacy with a safety profile consistent with other GnRH agonist formulations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
褚褚完成签到,获得积分10
刚刚
可爱的函函的应助被tang采纳,获得30
1秒前
沉静白凡完成签到,获得积分10
1秒前
dj完成签到,获得积分10
1秒前
小马甲的应助被Lee采纳,获得10
1秒前
zdx完成签到,获得积分10
2秒前
Jyouang发布了新的文献求助10
2秒前
一百完成签到,获得积分10
2秒前
qq完成签到,获得积分10
3秒前
莽兽鳞上最黑的皮完成签到,获得积分10
3秒前
3秒前
Gabriel1116发布了新的文献求助10
3秒前
科研通AI65的应助被xh采纳,获得10
4秒前
秋风的应助被yj采纳,获得10
4秒前
4秒前
WLM发布了新的文献求助10
4秒前
小魏小魏发布了新的文献求助10
4秒前
4秒前
4秒前
Sandclub发布了新的文献求助10
4秒前
ding的应助被Code_king采纳,获得50
4秒前
无限的鸵鸟完成签到,获得积分20
5秒前
5秒前
小鹿5460的应助被科研通管家采纳,获得10
5秒前
爆米花的应助被科研通管家采纳,获得10
5秒前
ding的应助被科研通管家采纳,获得10
5秒前
斯文败类的应助被科研通管家采纳,获得10
5秒前
爆米花的应助被科研通管家采纳,获得10
5秒前
YYBAS完成签到,获得积分10
5秒前
5秒前
DW的应助被xxxxxxzz采纳,获得10
5秒前
wuwa的应助被科研通管家采纳,获得10
5秒前
鳗鱼摇伽发布了新的文献求助20
5秒前
6秒前
cui完成签到,获得积分10
6秒前
搜集达人的应助被科研通管家采纳,获得10
6秒前
Earuan的应助被科研通管家采纳,获得10
6秒前
小二郎的应助被科研通管家采纳,获得10
6秒前
完美世界的应助被科研通管家采纳,获得10
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175943
求助须知:如何正确求助?哪些是违规求助? 9567501
关于积分的说明 21793186
捐赠科研通 7770490
什么是DOI,文献DOI怎么找? 3431935
关于科研通互助平台的介绍 2556294
邀请新用户注册赠送积分活动 2477485